Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 323 results for "cipla"

Live Market Updates: Sensex, Nifty rally, BHEL up 3%; FM arriv...

BHEL, Sesa Sterlite, HDFC, SBI and LT are top gainers in the Sensex. Among the Bharti Airtel, Cipla, Hero MotoCorp and Hindalco. Money Control, 3 days ago

58 images for cipla

India Infoline, 2 hours ago
Pharmafocus, 2 weeks ago
Asian Scientist, 1 week ago
Business Today India, 2 weeks ago
Sify, 2 weeks ago
NDTV Profit, 2 weeks ago, 2 weeks ago, 2 weeks ago, 2 weeks ago
MedIndia, 1 week ago

Live Market Updates: Nifty slips below 8900; TCS, Infosys, Hero laggards

TCS, Hero, Cipla, Maruti and Infosys are down while Tata Steel, HDFC, LT, ICICI Bank and BHEL are among the gainers in the Sensex.
 Money Control3 days ago Live Market Updates: Nifty holds 8900 as FM prepares for Budget speech; IT weak  Money Control3 days ago
Business Standard

Cipla Q3 net profit up

Cipla Limited, a pharmaceutical company, has reported that net profit after tax for the third quarter ended December 31, 2014 was INR3.34 billion, or INR4.07 per diluted share, compared to INR2.96 billion, or INR3.54 per diluted share, for the same ...
 Individual.com5 days ago Cipla reports 15% rise in Q3 consolidated net profit  Indian-Commodity2 weeks ago Cipla gains 5% on strong Q3 numbers  Business Standard2 weeks ago Cipla Q3 profit up 15% to Rs328 crore  Livemint.com2 weeks ago
Times of India

NPPA directs manufacturers to ensure consistent supply of swine flu medicines

The National Pharmaceutical Pricing Authority (NPPA) has directed the drug manufacturers Cipla, Hetero, Ranbaxy and Strides Acrolabs to ensure smooth supply of medicines following the rising number of deaths due to swine flu as also to meet soaring ...
 PharmaBiz1 week ago Maintain supply of swine flu drug: Govt to companies  Times of India2 weeks ago Stock up medicines: Body to pharma giants  Asian Age2 weeks ago

Cipla plans to acquire US-based pharma cos; stock inches up

MUMBAI: Stocks of Cipla advanced over 2 per cent on Thursday on reports that the pharma major is looking to increase its presence in the American market by acquiring US-based companies. Sources indicated that Cipla is in talks to acquire companies ...
 Economic Times1 week ago
India Infoline

Cipla, Mylan in race to acquire select brands of Sun Pharma: Reports

Othe rplayers are also in fray includes Intas pharma and Emcure.
 India Infoline1 week ago Cipla, Mylan in race to buy select brands of Sun Pharma put up for sale  Economic Times2 weeks ago

Cipla (Buy)

Centrum Broking CMP: ₹670.40 Target: ₹790 Cipla has reported 14 per cent y-o-y growth in domestic revenues (43 per cent of total) to ₹1,200 crore from ₹1,050 crore due to strong growth in respiratory, anti-infective, cardiovascular and ...
 Hindu Business Line2 weeks ago
Asian Scientist

Cipla Awarded US$189 Million Of Global Fund ARV Tender

Cipla has been selected by the Global Fund to produce anti-retroviral drugs for the next three years. Asian Scientist Newsroom | February 23, 2015 | Pharma AsianScientist (Feb. 23, 2015) - Cipla Ltd., an Indian pharmaceutical company, has ...
 Asian Scientist1 week ago Cipla receives $188.95 million of Global Fund ARV tender  Individual.com1 week ago CIPLA : Bags $188.95 million tender by global fund for arv drugs  4 Traders1 week ago Cipla gains on entering into binding term sheet to establish JV Company in Algeria  Arihant Capital2 weeks ago

Cipla sets up new plant in Morocco

Indian firm Cipla's UK subsidiary has entered into a joint venture to establish a stronger presence in Morocco, as it sets its sights on expansion into the Middle East and North African markets. The agreement, in which Cipla is investing $15 ...
 Pharmafocus2 weeks ago Cipla to form joint venture with Biopharm SPA for respiratory products  Economic Times2 weeks ago Cipla to form JV with Biopharm SPA for respiratory products  Press Trust of India2 weeks ago Cipla enters into pact with Biopharm for Algeria JV  India Infoline2 weeks ago

CIPLA : to name Gilead Sciences's hepatitis C generic drug Hepcvir

Mumbai : Pharmaceutical major Cipla plans to name its hepatitis C drug with Gilead Sciences as Hepcvir, its chairman Yusuf K Hamied on Wednesday. Last year Gilead Sciences has licensed its hepatitis C drug Sovaldi (chemically known as sofosbufir) to ...
 4 Traders1 week ago Cipla to name Gilead hepatitis C generic Hepcvir  DNA2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - cipla
Get updated on latest news & your favorite topics right in your inbox!
More     Less